Stock A002210 DONG SUNG BIO PHARM.CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Dong Sung Bio Pharm.Co.,Ltd.

Equities

A002210

KR7002210003

Pharmaceuticals

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-06-09 pm EDT 		5-day change 1st Jan Change
5,020 KRW -0.40% Intraday chart for Dong Sung Bio Pharm.Co.,Ltd. -0.20% -12.85%
2023 Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding CI
2023 Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding CI

Business Summary

Dongsung Pharmaceutical Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Company’s products include anti-rheumatic, anti-inflammatory analgesics, anti-inflammatory enzymes, drugs for cardiovascular system, gastrointestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dermatologicals, antibiotics, antidiarrheals, antifungals, oral hypoglycemic agents, hormones, hypnotics and others. It also produces hair dyes and cosmetics. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 290

Sales per Business

KRW in Million2022Weight2023Weight Delta
Medicine and Hair Dyes
94.9 %
86,729 92.9 % 84,114 94.9 % -3.01%
Cosmetics
5.1 %
6,599 7.1 % 4,480 5.1 % -32.12%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
81.6 %
86,040 92.2 % 72,321 81.6 % -15.95%
Overseas
18.4 %
7,288 7.8 % 16,273 18.4 % +123.28%

Managers

Managers TitleAgeSince
Yang-Gu Lee CEO
 Chief Executive Officer 62 -
Chan-Tae Ko AUD
 Comptroller/Controller/Auditor 65 -
Bong-Rim Cho PRN
 Corporate Officer/Principal 62 -
Sang-Yi Nam PRN
 Corporate Officer/Principal 64 -
In-Gyu Kim SAM
 Sales & Marketing 69 -

Members of the board

Members of the board TitleAgeSince
Yang-Gu Lee CEO
 Chief Executive Officer 62 -
Young-Ryul Lee BRD
 Director/Board Member 66 19-03-28
Won-Gyoon Na BRD
 Director/Board Member 38 22-03-27

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 26,100,970 17,319,767 ( 66.36 %) 3,234,982 ( 12.39 %) 66.36 %

Shareholders

NameEquities%Valuation
Yang-Gu Lee
17.05 %
4,451,261 17.05 % 17 M ₩
DONG SUNG BIO PHARM.CO.,LTD.
12.39 %
3,234,982 12.39 % 12 M ₩
Kyeong-hee Lee
1.553 %
405,310 1.553 % 2 M ₩
Yong-hoon Lee
1.260 %
328,899 1.260 % 1 M ₩
Won-Gyoon Na
1.152 %
300,667 1.152 % 1 M ₩
Ju-hyun Kim
0.1237 %
32,297 0.1237 % 121 280 ₩
Yong-joon Lee
0.1095 %
28,574 0.1095 % 107 300 ₩
DFA Australia Ltd.
0.003743 %
977 0.003743 % 3 669 ₩

Holdings

NameEquities%Valuation
DONG SUNG BIO PHARM.CO.,LTD.
12.39%
 3,234,982 12.39% 11,752,528 $

Company contact information

Dongsung Pharmaceutical Co., Ltd.

683 Dobong-ro Dobong-gu

01340, Seoul

+

http://www.dongsung-pharm.co.kr
address Dong Sung Bio Pharm.Co.,Ltd.(A002210)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
DONG SUNG BIO PHARM.CO.,LTD. Stock Dong Sung Bio Pharm.Co.,Ltd.
-12.85% 83.63M
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.14% 43.3B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+23.67% 22.22B
SANDOZ GROUP AG Stock Sandoz Group AG
+16.89% 15.43B
CIPLA LIMITED Stock Cipla Limited
+23.10% 14.48B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+57.58% 12.72B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-10.69% 6.71B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+14.68% 5.5B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. A002210 Stock
  4. Company Dong Sung Bio Pharm.Co.,Ltd.